Managing hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin
Zhen Wang, Junbo GeDepartment of Cardiology, Zhongshan Hospital, Shanghai, People's Republic of ChinaAbstract: Coronary heart disease (CHD) is the leading cause of death worldwide. The efficacy and safety of statins in primary and secondary prevention of CHD is confirmed in several large stu...
Guardado en:
Autores principales: | Wang Z, Ge JB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d4af42d90c74a8e8128587461e6b238 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
por: Sydney B Long, et al.
Publicado: (2010) -
A Comparison on Effects of High Dose Rosuvastatin versus High Dose Atorvastatin on Lipid Profile and CRP Level in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Study
por: Mahboubeh Darban, et al.
Publicado: (2021) -
LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA
por: ASHFAQ,MUHAMMAD, et al.
Publicado: (2013) -
Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
por: Marina G. Bubnova, et al.
Publicado: (2021) -
ROSUVASTATIN AS A POSSIBLE TREATMENT FOR SUDDEN SENSORINEURAL HEARING LOSS
por: Nadeem Ul Haq, et al.
Publicado: (2019)